The impact of decentralised drug-budgets in Sweden – a survey of physicians’ attitudes towards costs and cost-effectiveness
Authors:
- Sandra JanssonSJSandra Jansson
- Anders AnellAAAnders Anell
- 1 May 2006
- journal article
- Published by Elsevier in Health Policy
- Vol. 76 (3) , 299-311
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private careEuropean Journal of Clinical Pharmacology, 2001
- A survey of physician attitudes and practices concerning cost-effectiveness in patient careWestern Journal of Medicine, 2000
- The influence of economic evaluation studies on decision making.Health Policy, 2000
- Pharmacoeconomics and Clinical Practice GuidelinesPharmacoEconomics, 2000
- Prescription changes and drug costs at the Interface between primary and specialist careEuropean Journal of Clinical Pharmacology, 1998
- Economic evaluation under managed competition: Evidence from the U.K.Social Science & Medicine, 1997
- Fundholders' prescribing costs: the first five yearsBMJ, 1996
- Do Physicians Take Cost Into Account When Making Prescribing Decisions?PharmacoEconomics, 1995
- Coping with obligations towards patient and society: an empirical study of attitudes and practice among Norwegian physicians.Journal of Medical Ethics, 1995
- Prescription of antibiotics to out- patients in hospital clinics, community health centres and private practiceEuropean Journal of Clinical Pharmacology, 1990